Abstract:Objective To explore the research status of clinical efficacy evaluation indexes in the treatment of polycystic ovary syndrome (PCOS) with Chinese medicine. Methods CNKI, WanFang data, VIP, SinoMed, Web of Science, PubMed and other databases were used to search the clinical randomized controlled trials（RCTs）of Chinese medicine intervention in PCOS in the past 5 years. According to the inclusion and exclusion criteria, the relevant literatures meeting the requirements were screened out, and the data were extracted and analyzed. Results Finally, 190 RCTs were included, involving a total of 182 efficacy evaluation indicators. The number of indicators used in a single study ranged from 3 to 29, with a median of 10. The top 16 indexes in the frequency of use were: serum luteinizing hormone(LH), testosterone, follicle stimulating hormone(FSH), total effective rate, estrogen, ovulation rate, pregnancy rate, LH/FSH, Chinese medicine syndrome score, ovarian volume, insulin resistance index, fasting insulin, body mass index, endometrial thickness, fasting blood glucose, and number of follicles. There were great differences in the number and type of indicators in different studies. Some of the study indicators were divorced from clinical needs, lack of practicability, and lack of attention in long-term prognosis and safety indicators. Conclusion Objective and unified criteria should be adopted to evaluate clinical trials of PCOS treated by Chinese medicine, taking into account the characteristics of Chinese medicine, so as to improve the clinical value and methodological quality of relevant clinical studies.